CVS Health Corp (CVS)

97.59
0.32 0.33
NYSE : Health Care
Prev Close 97.27
Open 97.07
Day Low/High 97.05 / 97.44
52 Wk Low/High 86.50 / 106.67
Volume 135.57K
Avg Volume 4.88M
Exchange NYSE
Shares Outstanding 1.07B
Market Cap 104.49B
EPS 4.70
P/E Ratio 22.63
Div & Yield 1.70 (1.70%)

Latest News

CVS Health Research Institute Study Shows Value In Tailoring Medication Adherence Interventions To Specific Patient Populations

CVS Health Research Institute Study Shows Value In Tailoring Medication Adherence Interventions To Specific Patient Populations

Interventions focused on keeping patients adherent as well as those focused on patients with three or more chronic conditions can result in significant cost savings

Cramer: Retail's too Strong to Keep Whining

Cramer: Retail's too Strong to Keep Whining

Mall and brick-and-mortar stores can still shine.

AAPL, CVS, URBN: Jim Cramer's Views

AAPL, CVS, URBN: Jim Cramer's Views

Cramer shares his views on Target's excuses. Apple, CVS and Urban Outfitters are among the stocks discussed.

Trifecta Stocks Weekly Roundup

This week Whirlpool jumped into the portfolio pool, where it joined recent additions Sherwin-Williams and International Flavors & Fragrances.

CVS Health And The CVS Health Foundation Announce $100K Donation In Support Of Louisiana Flood Relief Efforts

CVS Health And The CVS Health Foundation Announce $100K Donation In Support Of Louisiana Flood Relief Efforts

Company to deploy mobile pharmacy and other in-kind needs to hard hit communities

Why Selling Drugs Has Gotten Tougher for Target

Why Selling Drugs Has Gotten Tougher for Target

Target's big move to profit from installing CVS pharmacies in its stores hit a speed bump in the second quarter.

Cramer: Target's Excuses Really Don't Cut It

Cramer: Target's Excuses Really Don't Cut It

This was the quarter of bricks-and-mortar retail -- just not Target's bricks and mortar.

Target Blames Apple, Two Other Things for Weak Sales

Target Blames Apple, Two Other Things for Weak Sales

Target's sales declined in the second quarter amid a challenging retail environment.

CVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy Locations In Colorado

CVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy Locations In Colorado

Nearly 40 CVS Pharmacy locations in Colorado can now dispense naloxone

3 Stocks With Income and Upside Despite Market's New Highs

3 Stocks With Income and Upside Despite Market's New Highs

Becton Dickinson, CVS and General Dynamics offer value even after the recent run-up in stocks.

CVS Health Survey Reveals Two In Five Americans Make Multiple Trips To Get Entire Household Vaccinated Against The Flu

CVS Health Survey Reveals Two In Five Americans Make Multiple Trips To Get Entire Household Vaccinated Against The Flu

Convenience found to be major factor in determining where Americans get a flu shot

What CVS and Express Scripts' Drug Exclusion Lists Means for Your Portfolio

What CVS and Express Scripts' Drug Exclusion Lists Means for Your Portfolio

Earlier this month the two major pharmacy benefit managers, CVS Caremark CVS and Express Scripts ESRX released lists of drugs they will no longer cover in 2017.

Trifecta Stocks Weekly Roundup

This week we promoted International Flavors & Fragrances from the Bullpen and added it to our active portfolio, where it joined recent newbie Sherwin-Williams.

July Retail Sales Don't Change Our View

Even though overall sales were weaker than expected, the underlying shifts that are at the heart of several of our positions remain very much intact.

CVS Health Makes Overdose-Reversal Drug Naloxone Available Without A Prescription In Idaho

CVS Health Makes Overdose-Reversal Drug Naloxone Available Without A Prescription In Idaho

CVS Pharmacy is now located inside Target stores in Nampa and Twin Falls

This Is an Over-the-Top Stock

What can happen when a stock that's down turns around.

CVS Pharmacy Launches Breakthrough, End-to-End Mobile Payment Experience

CVS Pharmacy Launches Breakthrough, End-to-End Mobile Payment Experience

New CVS Pay pilot enables customers to receive ExtraCare deals, pick-up prescriptions and pay - all with one scan at checkout

CVS Health (CVS) Stock Higher, Earnings Estimates Raised at Leerink

CVS Health (CVS) Stock Higher, Earnings Estimates Raised at Leerink

CVS Health's (CVS) earnings estimates were increased at Leerink this morning as the firm said it continues 'to be positive on CVS' long-term fundamentals.'

Week in Review: S&P 500 Ends First Week of August Positive After Robust Jobs Report

Week in Review: S&P 500 Ends First Week of August Positive After Robust Jobs Report

A blowout July jobs report helped push both the S&P 500 and Nasdaq to record high closes on Friday.

Trifecta Stocks Weekly Roundup

We welcomed paint maker Sherwin-Williams into the Trifecta portfolio fold this week.

5 Blue-Chip Breakouts to Buy for Earnings Season

5 Blue-Chip Breakouts to Buy for Earnings Season

Here's a technical look at how to trade five large-cap stocks that are nearing breakout buy signals.

AAP Portfolio Cites Occidental's 'Discipline, Flexibility'

AAP Portfolio Cites Occidental's 'Discipline, Flexibility'

Company earnings in line while revenues miss in 'beleaguered oil environment.'

How Will CVS Health Stock Be Affected By Shift to Cheaper Copies of Drugs?

How Will CVS Health Stock Be Affected By Shift to Cheaper Copies of Drugs?

CVS Health announced on Tuesday that it was stopping coverage of 35 new drugs in 2017 and 131 in total, up from 124 in 2016.

CVS (CVS) Stock Earnings Estimates Raised at Barclays on Q2 Earnings, Guidance

CVS (CVS) Stock Earnings Estimates Raised at Barclays on Q2 Earnings, Guidance

CVS Health (CVS) stock earnings estimates were increased at Barclays this morning after reporting 2016 second quarter results Tuesday.

Keeping Our Price Target on CVS After Earnings

The company narrowed and raised its guidance.

Stocks Sink as Crude Oil, Auto Sales Encourage Bears

Stocks Sink as Crude Oil, Auto Sales Encourage Bears

Another selloff in crude oil and a disappointing July for automakers kept stocks firmly in the red on Tuesday in what has been a disappointing start to August.

Stocks Hold Lower as Crude Closes at Worst Level Since April

Stocks Hold Lower as Crude Closes at Worst Level Since April

Stocks hold near session lows by late Tuesday as crude oil closes below $40 a barrel for the first time since April.

Trending Tickers: MNK, FTR, DISCA, CVS

Trending Tickers: MNK, FTR, DISCA, CVS

Markets were falling as oil prices continued their two-month descent below $40 a barrel.